The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 1, 2004, Pages 15-25

  Straumann, A ^a   Simon, H U ^b  

^a Kantonsspital Olten ^*  (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Eosinophilic gastroenteritis; Eosinophilic oesophagitis; Eosinophils; Gastrointestinal tract; Hypereosinophilic syndrome; Oesophagitis

Indexed keywords

CELL FUNCTION; EOSINOPHIL; ESOPHAGITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; HEMATOPOIESIS; HUMAN; INFLAMMATION; PARASITOSIS; PRIORITY JOURNAL; REVIEW;

DIGESTIVE SYSTEM; EOSINOPHILIA; EOSINOPHILS; ESOPHAGITIS; FEMALE; GASTRIC MUCOSA; GASTROENTERITIS; HUMANS; HYPEREOSINOPHILIC SYNDROME; INTESTINAL MUCOSA; MALE; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0842330437     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1398-9995.2003.00382.x     Document Type: Review

References (98)

1. TACHIMOTO H, BOCHNER BS: The surface phenotype of human eosinophils. In: MARONE G, editor. Human eosinophils, biological and clinical aspects. Basel: Karger, 2000;76:45-62.
2. WELLER PF. The immunobiology of eosinophils. N Engl J Med 1991;324:1110-1118.
3. SEHMI R, DENBURG J. Differentiation of human eosinophils. In: MARONE G, editor. Human eosinophils, biological and clinical aspects. Basel: Karger, 2000;76:29-44.
4. KATO M, KEPHART GM, TALLEY NJ, WAGNER JM, SARR MG, BONNO M et al. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 1998;252:418-425.
5. SIMON HU, YOUSEFI S, SCHRANZ C, SCHAPOWAL A, BACHERT C, BLASER K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue esoinophilia. J Immunol 1997;158:3902-3908.
6. SIMON HU, WEBER M, BECKER E, Zilberman, Blaser K, Levi-Schaffer F. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist. Trastructural analysis of human eosinophils. J Immunol 2000;165:4069-4075.
7. SIMON HU, PLÖTZ S, SIMON D, SEITZER U, BRAATHEN LR, MENZ G et al. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Well's syndrome. Eur J Immunol 2003;33:834-839.
8. MOQBEL R, LEVI-SCHAFFER F, KAY AB. Cytokine generation by eosinophils. J Allerg Clin Immunol 1994;94:1183-1188.
9. SCHMID-GRENDELMEIER P, ALTZNAUER F, FISCHER B, BIZER C, STRAUMANN A, MENZ G et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 2002;169:1021-1027.
10. WELLER PF, RAND TH, BARRETT T, ELOVIC A, WONG DT, FINBERG RW. Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol 1993;150:2554-2562.
11. MAWHORTER SD, KAZURA JW, BOOM WH. Human eosinophils as antigen-presenting cells: relative efficiency for superantigen-and antigen-induced CD4+ T-cell proliferation. Immunology 1994;81:584-591.
12. BINDER HJ. Disorders of absorption. In: ISSELBACHER KJ, ADAMS RA, BRAUNWALD E, PETERSDORF RG, WILSON JD, eds. Harrison's principles of internal medicine, 15th edn. New York: McGraw-Hill, 2001; 1665-1679.
13. GUARNER F, MALAGELADA JR. Gut flora in health and disease. Lancet 2003;361:512-519.
14. BUTTERTON JR, CALDERWOOD SB. Acute infectious diseases and bacterial poisoning. In: ISSELBACHER KJ, ADAMS RA, BRAUNWALD E, PETERSDORF RG, WILSON JD, eds. Harrison's principles of internal medicine, 15th edn. New York: McGraw-Hill, 2001: 834-839.
15. PODOLSKY DK. Inflammatory bowel disease. N Engl J Med 2002;347: 417-429.
16. LOWICHIK A, WEINBERG AG. A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract. Mod Pathol 1996;9:110-114.
17. H2-type allergic inflammatory response. J Allergy Clin Immunol 2001;108:954-961.
18. MISHRA A, HOGAN SP, LEE JJ, FOSTER PS, ROTHENBERG ME. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 1999;103:1719-1727.
19. ROTHENBERG ME. Mechanisms of disease: eosinophilia. N Engl J Med 1998;338:1592-1600.
20. MISHRA A, HOGAN SP, BRANDT EB, ROTHENBERG ME. IL-5 promotes eosinophil trafficking to the oesophagus. J Immunol 2002;168:2464-2469.
21. c). Blood 1996;87: 4286-4295.
22. ELSNER J, KAPP A. Activation of human eosinophils by chemokines. Chem Immunol 2000;76:177-207.
23. SIMON HU, BLASER K. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol Today 1995;16:53-55.
24. STRAUMANN A, SPICHTIN HP, SIMON HU, PIROVINO M, BEGLINGER C. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 12 years. Gastroenterol 2003;124:M874.
25. BAUER S, SCHAUB N, DOMMANN CC, ZIMMERMANN DR, SIMON HU, WEGMANN W. Long-term outcome of idiopathic hypereosinophilic syndrom - transition to eosinophilic gastroenteritis and clonal expansion of T-cells. Eur J Gastroenterol Hepatol 1996;8:181-185.
26. WELLER PF, BUBLEY GJ. The idiopathic hypereosinophilic syndrome. Blood 1994;83:2759-2779.
27. ROTHENBERG ME, MISHRA A, COLLINS MH, PUTNAM PE. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol 2001;108:891-894.
28. Fox VL, NURKO S, FURUTA GT. Eosinophilic esophagitis: it's not just kid's stuff. Gastrointest Endosc 2002;56:260-270.
29. ATTWOOD SE, SMYRK TC, DEMEESTER TR, JONES JB. Esophageal eosinophilia with dysphagia, a distinct clinicopathologic syndrome. Dig Dis Sci 1993;38:109-116.
30. VITELLAS KM, BENNETT WF, BOVA JG, JOHNSTON JC, CALDWELL JH, MAYLE JE. Idiopathic eosinophilic esophagitis. Radiol 1993;186:789-793.
31. STRAUMANN A, SPICHTIN HP, BERNOULLI R, LOOSLI J, VOEGTLIN J. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr 1994;124:1419-1429.
32. DESAI T, GOLDSTEIN N, STECEVIC V, BADIAZDAN K, FURUTA G. Esophageal eosinophilia is common among adults with esophageal food impaction. Gastroenterol 2002;122:M1723.
33. KELLY KJ, LAZENBY AJ, ROWE PC, YARDLEY JH, PERMAN JA, SAMPSON HA. Eosinophilic esophagitis attributet to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterol 1995;109:103-112.
34. LIACOURAS CA, WENNER WJ, BROWN K, RUCHELLI E. Primary eosinophilic esophagitis in children: succsessful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998;26:380-385.
35. WALSH SV, ANTONIOLI DA, GOLDMAN H, FOX VL, BOUSVAROS A, LEICHTNER AM et al. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 1999;23:390-396.
36. ORENSTEIN SR, SHALABY TH, DILORENZO C, PUTNAM PE, SIGURDSSON L, KOCOSHIS SA. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000;95:1422-1430.
37. STRAUMANN A, SPICHTIN HP, SIMON HU, BEGLINGER C. Primary eosinophilic esophagitis: diagnostic accuracy of upper endoscopy. Gastroenterol 2003;124:M1785.
38. AHMED A, MATSUI S, SOETIKNO R. A novel endoscopic appearance of idiopathic eosinophilic esophagitis. Endoscopy 2000;32:33.
39. MUENCH R, KUHLMANN U, MAKEK M, AMMANN R, SIEGENTHALER W. Eosinophile oesophagitis, eine seltene manifestation der eosinophilen gastroenteritis. Schweiz Med Wochenschr 1982;112:731-734.
40. SPERGEL JM, BEAUSOLEIL JL, MASCARENHAS M, LIACOURAS CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002;109:363-368.
41. MISHRA A, HOGAN SP, BRANDT EB, ROTHENBERG ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001;107:83-90.
42. FAUBION WA, PERRAULT J, BURGART LJ, ZEIN NN, CLAWSON ML, FREESE DK. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998;27:90-93.
43. LANGDON DE. Fluticasone in eosinophilic corrugated ringed esophagus. Am J Gastroenterol 2001;96:926-927.
44. ATTWOOD SE, LEWIS CJ, BRONDER CS, MORRIS CD, ARMSTRONG GR, WHITTAM J. Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut 2003;52:181-185.
45. STRAUMANN A, ROSSI L, SIMON HU, HEER P, SPICHTIN HP, BEGLINGER C. Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Gastrointest Endosc 2003;57:407-412.
46. KHAN S, ORENSTEIN SR. Eosinophilic gastroenteritis: epidemiology, diagnosis and management. Paediatr Drugs 2002;4:563-570.
47. CELLO JP. Eosinophilic gastroenteritis - a complex disease entity. Am J Med 1979;67:1097-1104.
48. TALLEY NJ, SHORTER RG, PHILLIPS SF, ZINSMEISTER AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer and subserosal tissues. Gut 1990;31:54-58.
49. DOBBINS JW, SHEAHAN DG, BEHAR J. Eosinophilic gastroenteritis with esophageal involvement. Gastroenterol 1977;72:1312-1316.
50. MATZINGER M, DANEMAN A. Esophageal involvement in eosinophilic gastroenteritis. Pediatr Radiol 1983;13:35-38.
51. KATZ AJ, GOLDMAN H, GRAND RJ. Gastric mucosal biopsy in eosinophilic gastroenteritis. Gastroenterol 1977;73:705-709.
52. NAVAB F, KLEINMAN MS, ALGAZY K, SCHENK E, TURNER MD. Endoscopic diagnosis of eosinophilic gastritis. Gastrointest Endosc 1972;19:67-69.
53. COLON AR, SORKIN LF, STERN WR, LESSINGER VS, HEFTER LG, HODIN E. Eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr 1983;2:187-189.
54. MOORE D, LICHTMAN S, LENTZ J, STRINGER D, SHERMAN P. Eosinophilic gastroenteritis presenting in an adolescent with isolated colonie involvement. Gut 1986;27:1219-1222.
55. DABBS DJ. Eosinophilic and lymphoeosinophilic cholecystitis. Am J Surg Pathol 1993;17:497-501.
56. FLEJOU JF, POTET F, BERNADES P. Eosinophilic pancreatitis: a rare manifestation of digestive allergy? Gastroenterol Clin Biol 1989;13:731-733.
57. SOLIS-HERRUZO JA, DE CUENCA B, MUNOZ-YAGUE MT. Laparoscopic findings in serosal eosinophilic gastroenteritis. Endoscopy 1988;20:152-153.
58. KLEIN NC, HARGROVE RL, SLEISENGER MH, JEFFRIES GH. Eosinophilic gastroenteritis. Medicine 1970;49:299-319.
59. REMACHA-TOMEY B, COLOM J, RIPOLLES V, CORTES-VIZCAINO V, VERA-ROMAN J. Primary intestinal T lymphoma with massive eosinophilia. Gastroenterologia y Hepatologia 1999;22:82-85.
60. KAIJSER R. Zur Kenntnis der allergischen Affektionen des Verdauungskanals vom Standpunkt des Chirurgen aus. Langenbecks Arch Klin Chir 1937;188:36-64.
61. GUAJARDO J, PLOTNICK L, FENDE J, COLLINS M, PUTNAM P, ROTHENBERG M. Eosinophil-associated gastrointestinal disorders: a world wide web based registry. J Pediatr 2002;141:576-581.
62. LEINBACH GE, RUBIN CE. Eosinophilic gastroenteritis: a simple reaction to food allergens? Gastroenterol 1970;59:874-709.
63. RAUSCH T, GYR K, WMANN W, GERMER M, MEIER R. Symptomatische Therapie einer schweren Diarrhoe bei eosinophiler Gastroenteritis mit dem Somatostatinanalog Octreotid. Schweiz Med Wochenschr 1997;127:S9-13.
64. SACHER P. Surgical aspects of eosinophilic gastroenteritis. Z Kinderchir 1981;34:25-30.
65. DESREUMAUX P, BLOGET F, SUY D, CAPRON M, CORTOT A, COLOMBEL JF et al. IL-3, GM-CSF, and IL-5 in eosinophilic gastroenteritis. Gastroenterol 1996;110:768-774.
66. MOOTS RJ, PROUSE P, GUMPEL JM. Near fatal eosinophilic gastroenteritis responding to oral sodium chomoglycate. Gut 1988;29:1282-1285.
67. Di GIOACCHINO M, PIZZICANNELLA G, FINI N, FALASCA F, ANTINUCCI R, MASCI S et al. Sodium cromoglycate in the treatment of eosinophilic gastroenteritis. Allergy 1990;45:161-166.
68. MELAMED I, FEANNY SJ, SHERMAN PM, ROIFMAN CM. Benefit of ketotifen in patients with eosinophilic gastroenteritis. Am J Med 1991;90:310-314.
69. NEUSTROM MR, FRIESEN C. Treatment of eosinophilic gastroenteritis with montelukast. J Allergy Clin Immunol 1999;104:506.
70. CHUSID MJ, DALE DC, WEST BC, WOLFF SM. The hypereosinophilic syndrome: analysis of fourteen cases with rewiev of the literature. Medicine 1975;54:1-27.
71. LEFEBVRE C, BLETRY O, DEGOULET P, GUILLEVIN L, BENTATA-PESSAYRE M, LETHIHUONG D et al. Prognostic factors of hypereosinophilic syndrome: study of 40 cases. Ann Med Interne 1989;140:253-257.
72. SPRY CJ, DAVIES J, TAI PC, OLSEN EG, OAKLEY CM, GOODWIN JF. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 1983;52:1-22.
73. ASSA'AD AH, SPICER RL, NELSON DP, ZIMMERMANN N, ROTHENBERG ME. Hypereosinophilic syndromes. In: MARONE G, editor. Human eosinophils, biological and clinical aspects. Basel: Karger, 2000;76:208-229.
74. SIMON HU, PLÖTZ SG, DUMMER R, BLASER K. Abnormal clones of T Cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999;341:1112-1120.
75. OWEN WF, ROTHENBERG ME, PETERSEN J, WELLER PF, SILBERSTEIN D, SHEFFER AL et al. Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 1989;170:343-348.
76. DE LAVAREILLE A, ROUFOSSE F, SCHMID-GRENDELMEIER P, ROUMIER AS, SCHANDENE L, COGAN E et al. High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome. J Allergy Clin Immunol 2002;110:476-479.
77. MENSSEN HD, RENKL HJ, RIEDER H, BARTELT S, SCHMIDT A, NOTTER M et al. Distinction of eosinophilia leukemia from idiopathic hypereosinophilic syndromes by analysis of Wilm's tumor gene expression. Br J Haematol 1998;101:325-334.
78. COOLS J, DEANGELO DJ, GOTLIB J, STOVER EH, LEGARE RD, CORTES J et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of Imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-1214.
79. FAUCI AS, HARLEY JB, ROBERTS WC, FERRANS VJ, GRALNICK HR, BJORNSON BH. NIH Conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiological, and therapeutic considerations. Ann Intern Med 1982;97:78-92.
80. BUTTERFIELD JH, GLEICH GJ. Response of six patients with idiopathic hypereosinophilic syndrome to interferon alpha. J Allergy Clin Immunol 1994;94:1318-1326.
81. SIMON HU. The neutralization of interleukin-5 as a therapeutic concept in allergic inflammation. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:25-28.
82. DAVIDSON RA. Immunology of parasitic infections. Med Clin North Am 1985;107:208-210.
83. BIRCHER AJ, GYSI B, ZENKLUSEN HR, AERNI R. Eosinophilic oesophagitis associated with recurrent urticaria: is there a worm (Anisakis simplex) in the rose? Schweiz Med Wochenschr 2000;130:1814-1819.
84. GOMEZ B, TABAR AI, TUNON T, LARRINAGA B, ALVAREZ MJ, GARCIA BE et al. Eosinophilic gastroenteritis and Anisakis. Allergy 1998;53: 1148-1154.
85. PAMPIGLIONE S, RIVASI S, CRISCUOLO M, DE BENEDITTIS A, GENTILE ARS, TESTINI M et al. Human anisakiasis in Italy: a report of eleven new cases. Pathol Res Pract 2002;198:429-434.
86. UBEIRA FM. Prevalence of and risk factors for IgE sensitization to Anisakis simplex in a Spanish population. Allergy 2001;56:667-671.
87. SHIELDS BA, BIRD P, LISS WJ, GROVES KL, OLSON R, ROSSIGNOL PA. The nematode Anisakis simplex in American shad (Alosa sapidissima) in two Oregon rivers. J Parasitol 2002;88:1033-1035.
88. DASCHNER A, ALONSO-GOMEZ A, CABANAS R, SUAREZ-DE-PARGA JM, LOPEZ-SERRANO MC. Gastroallergic Anisakis: borderline between food allergy and parasitic disease - clinical and allergologic evaluation of 20 patients with confirmed acue parasitism by Anisakis simplex. J Allergy Clin Immunol 2000;105:178-181.
89. LORENZO S, IGLESIAS R, LEIRO J, UBEIRA FM, ANSOTEGUI I, GARCIA M et al. Usefulness of currently available methods for the diagnosis of Anisakis simplex allergy. Allergy 2000;55:627-633.
90. COHEN S, PARKMEN HP. Diseases of the esophagus. In: CECIL RL, GOLDMAN L, BENNETT JC, editors. Cecil textbook of medicine, 21st edn. Philadelphia, PA: W.B. Saunders, 2000:658-668.
91. KAHRILAS PJ. Gastroesophageal reflux disease and its complications. In: SLEISENGER MH, SCHARSCHMIDT B, SLEISENGER MH, KLEIN S, editors. Sleisenger and Fordtran's gastrointestinal and liver disease pathophysiology, diagnosis, management, 6th edn. Philadelphia, PA: W.B. Saunders, 1998:498-514.
92. BROWN LF, GOLDMANN H, ANTONIOLO DA. Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol 1984;8:899-905.
93. WRIGHT R, TRUELOVE SC. Circulating and tissue eosinophils in ulcerative colitis. Am J Dig Dis 1966;11:831-846.
94. BINDER V. Cell density in lamina propria of the colon. A quantitative method applied to normal subjects and ulcerative colitis patients. Scand J Gastroenterol 1970;5:485-490.
95. JEZIORSKA M, HABOUDI N, SCHOFIELD P, WOLLEY DE. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistological technique. J Pathol 2001;194:484-492.
96. BERSTAD A, BORKJE B, RIEDL B, ELSAYED S, BERSTAD A. Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepatogastroenterol 1993;40:276-278.
97. HEATLEY RV, JAMES PD. Eosinophils in the rectal mucosa. A simple method of predicting the outcome of ulcerative proctocolitis? Gut 1979;20:787-791.
98. D'ARIENZO A, MANGUSO F, ASTARITA C, D'ARMIENTO FP, SCARPA R, GARGANO D et al. Allergy and mucosal eosinophil infiltrate in ulcerative colitis. Scand J Gastorenterol 2000;35:624-631.